Dear Editor, This is with respect to the article by Gill et al., published in January-March issue of IJMM, 2015, regarding new synthetic tripeptide inhibiting Candida krusei. [1] Such inhibitory potential is also shown by Pyocyanin, a pigment synthesised by Pseudomonas aeruginosa, both heated and unheated. [2] These natural inhibitory compounds have renewed interest in the development of antifungal agents. Furthermore, the authors have not shown the toxicity of this new tripeptide compound on cell lines or any other cell types other than red blood corpuscles. Another substance that has documented such inhibitory potential is the culture filtrate of Aspergillus flavus. [3] Both the substances mentioned also inhibit biofilm development in Candida albicans and Candida tropicalis, and have been proven to be non-toxic in Hep-2 cell line assay. They also inhibit lipase, a potent virulence factor and enzyme of Candida spp., especially C. albicans. Further studies on animal systems have to be done before any of these compounds can be thought to be used in clinical practice to inhibit Candida biofilms. Another aspect
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Rapid action by Chandigarh: Flew away the threat of bird flu
Dear Editor,
The peaceful life of the beautiful city, Chandigarh, was disrupted one December winter morning when the newspapers reported that one of the samples from a goose that had died at Sukhna Lake, tested positive for the deadly avian influenza virus (H5N1) at the National Institute of High Security Animal Diseases Laboratory, Bhopal. [1] This sample was tested owing to the spontaneous death of over 30 geese at the lake. The outbreak was attributed to the migratory birds. This is the first time that India has witnessed H5N1 outbreak among non-commercial captive geese. However, the rapid response team of the Chandigarh Administration came into action and was followed by the immediate culling of approximately 110 geese. [2] The centre issued a sanitisation certificate to the Chandigarh Administration as the immediate fear of the spread of infection was controlled. [2] All the school children who had visited the lake were followed up, schools within a radius of 3 km were closed and the lake was closed to the visitors. [3] An urgent response helped to contain the virus, which was further possible due to the ongoing preparedness in India in response to the high alert created due to the ongoing Ebola outbreak in Africa. Till date, no human infections have been reported in India, though worldwide a total of 676 confirmed human cases of H5N1 and 398 deaths have been reported. [4] Currently, the best way to prevent infection with avian influenza A viruses is to avoid sources of exposure whenever possible. For treatment (and prevention), oseltamivir or zanamivir is recommended. The stockpiled vaccine could be used if a H5N1 virus begins transmitting easily from person to person. A new recombinant A (H5N1) vaccine virus has been developed by the National Institute of Virology, Pune, India. H5N1 outbreak in Chandigarh was well controlled and Sukhna Lake was opened after 1-month. [5] Financial support and sponsorship Nil.
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